Colorectal Cancer Screening Market: By End user (Hospitals, Diagnostic laboratories and Others); By Screening Test (Flexible Sigmoidoscopy, Stool-Based Tests, CT Colonography and Colonoscopy), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032
Colorectal Cancer Screening Market: By End user (Hospitals, Diagnostic laboratories and Others); By Screening Test (Flexible Sigmoidoscopy, Stool-Based Tests, CT Colonography and Colonoscopy), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032
PRODUCT OVERVIEW
Bowel cancer and colon cancer are other names for colorectal cancer (CRC). It is the growth of cancer in the colon or rectum. With colonoscopy, a thorough diagnosis and effective therapy are possible without a big operation. The polyps can also be removed with a colonoscope. Adenomas, polyps, and illness signs can all be found using diagnostic processes employed in colorectal cancer screening tests in vitro. The large intestine, colon, and rectum exhibit aberrant cell proliferation in colorectal cancer, a medical disorder. The market for in colorectal cancer screening is anticipated to grow in response to the increased incidence of the disease.
MARKET HIGHLIGHTS
The Colorectal Cancer Screening Market is expected to project a notable CAGR of 6.8% in 2032.
Colorectal Cancer Screening Market is expected to surpass USD 29.10 billion by 2032 from USD 16.24 billion in 2021 at a CAGR of 6.8% in the coming years, i.e., 2022-32. The government's increased investment in R&D and the demand for early diagnoses are anticipated to fuel market expansion. Additionally, the market growth is boosted by the extensive research and development conducted by commercial and public organisations. Over the course of the forecast period, factors such the rising incidence of colorectal cancer, recommendations from government agencies for early screening, technical improvements, and the introduction of new products are projected to boost market expansion.
COLORECTAL CANCER SCREENING MARKET: SEGMENTS
The Colonoscopy segment is expected to grow with a higher CAGR during 2022-32
Colorectal Cancer Screening Market is categorized on the basis of Screening Test into Flexible Sigmoidoscopy, Stool-Based Tests, CT Colonography and Colonoscopy. In 2021, the Colonoscopy segment held the highest this is due to the screening test's global ability to recognise and effectively eradicate both pro-malignant and malignant tumours.
The hospitals segment is expected to grow with a higher CAGR during 2022-32
Colorectal Cancer Screening Market is categorized on the basis of end user into Hospitals, Diagnostic laboratories and Others. The hospitals sector generated the largest revenue share in 2021 and had a profitable CAGR throughout the projection period. This is attributable to the rise in colorectal cancer cases and improvements in screening methods used in hospitals around the world. Independent diagnostic laboratories are anticipated to experience profitable CAGR growth during the predicted period. The reason for this is that there are now more tests being performed in these labs as a result of patients' growing knowledge of the advantages of early cancer detection.
MARKET DYNAMICS
Growth Drivers
Rising Cases of Cancer and Increased Use of Healthcare Equipment Is Driving Growth
Poor Eating Habits, Lifestyle Changes and Urban Air Pollution Are Expected to Surge Demand
Restraint
Lack Of Experienced Workers and High Equipment Cost Is Likely to Hamper the Market Growth
COLORECTAL CANCER SCREENING MARKET:
Key Players
Colorectal Cancer Screening Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. In 2021, North America had the largest share in the market of Colorectal Cancer Screening. Government initiatives regarding promotion of efficient treatment facilities is also likely to promote growth in the North American region. Over the course of the forecast period, factors such the rising incidence of colorectal cancer, recommendations from government agencies for early screening, technical improvements, and the introduction of new products are projected to boost market expansion in the region of North America.
COLORECTAL CANCER SCREENING MARKET REPORT ALSO CONTAINS ANALYSIS ON:
Colorectal Cancer Screening Market Segments:
PRODUCT OVERVIEW
Bowel cancer and colon cancer are other names for colorectal cancer (CRC). It is the growth of cancer in the colon or rectum. With colonoscopy, a thorough diagnosis and effective therapy are possible without a big operation. The polyps can also be removed with a colonoscope. Adenomas, polyps, and illness signs can all be found using diagnostic processes employed in colorectal cancer screening tests in vitro. The large intestine, colon, and rectum exhibit aberrant cell proliferation in colorectal cancer, a medical disorder. The market for in colorectal cancer screening is anticipated to grow in response to the increased incidence of the disease.
MARKET HIGHLIGHTS
The Colorectal Cancer Screening Market is expected to project a notable CAGR of 6.8% in 2032.
Colorectal Cancer Screening Market is expected to surpass USD 29.10 billion by 2032 from USD 16.24 billion in 2021 at a CAGR of 6.8% in the coming years, i.e., 2022-32. The government's increased investment in R&D and the demand for early diagnoses are anticipated to fuel market expansion. Additionally, the market growth is boosted by the extensive research and development conducted by commercial and public organisations. Over the course of the forecast period, factors such the rising incidence of colorectal cancer, recommendations from government agencies for early screening, technical improvements, and the introduction of new products are projected to boost market expansion.
COLORECTAL CANCER SCREENING MARKET: SEGMENTS
The Colonoscopy segment is expected to grow with a higher CAGR during 2022-32
Colorectal Cancer Screening Market is categorized on the basis of Screening Test into Flexible Sigmoidoscopy, Stool-Based Tests, CT Colonography and Colonoscopy. In 2021, the Colonoscopy segment held the highest this is due to the screening test's global ability to recognise and effectively eradicate both pro-malignant and malignant tumours.
The hospitals segment is expected to grow with a higher CAGR during 2022-32
Colorectal Cancer Screening Market is categorized on the basis of end user into Hospitals, Diagnostic laboratories and Others. The hospitals sector generated the largest revenue share in 2021 and had a profitable CAGR throughout the projection period. This is attributable to the rise in colorectal cancer cases and improvements in screening methods used in hospitals around the world. Independent diagnostic laboratories are anticipated to experience profitable CAGR growth during the predicted period. The reason for this is that there are now more tests being performed in these labs as a result of patients' growing knowledge of the advantages of early cancer detection.
MARKET DYNAMICS
Growth Drivers
Rising Cases of Cancer and Increased Use of Healthcare Equipment Is Driving Growth
Poor Eating Habits, Lifestyle Changes and Urban Air Pollution Are Expected to Surge Demand
Restraint
Lack Of Experienced Workers and High Equipment Cost Is Likely to Hamper the Market Growth
COLORECTAL CANCER SCREENING MARKET:
Key Players
- Sysmex Corporation
- Hemosure Inc
- Epigenomics Inc
- Novigenix SA
- Clinical Genomics Technologies
- Quidel
- Siemens
- GE Healthcare
- Abbott
- Exact Sciences
- Other Prominent Players
Colorectal Cancer Screening Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. In 2021, North America had the largest share in the market of Colorectal Cancer Screening. Government initiatives regarding promotion of efficient treatment facilities is also likely to promote growth in the North American region. Over the course of the forecast period, factors such the rising incidence of colorectal cancer, recommendations from government agencies for early screening, technical improvements, and the introduction of new products are projected to boost market expansion in the region of North America.
COLORECTAL CANCER SCREENING MARKET REPORT ALSO CONTAINS ANALYSIS ON:
Colorectal Cancer Screening Market Segments:
- By Screening Test
- Stool-Based Tests
- Flexible Sigmoidoscopy
- CT Colonography
- Colonoscopy
- By End use
- Hospitals
- Diagnostic Laboratories
- Others
- Colorectal Cancer Screening Market Dynamics
- Colorectal Cancer Screening Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Value Chain of the Market
- Market Drivers and Restraints
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1.Regional Market Share
1.2.Business Trends
1.3. Colorectal Cancer Screening Market: COVID-19 Outbreak
1.4.Regional Trends
1.5.Segmentation Snapshot
2.RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3.MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Colorectal Cancer Screening Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4.COLORECTAL CANCER SCREENING MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5.MACROECONOMIC INDICATORS
6.RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8.RISK ANALYSIS
9.MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1.Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10.COLORECTAL CANCER SCREENING MARKET
10.1. Overview
10.2. Historical Analysis (2016-2021)
10.2.1.Market Size, Y-o-Y Growth (%) and Market Forecast
11.COLORECTAL CANCER SCREENING MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Screening Test
11.3.1.1.Flexible Sigmoidoscopy
11.3.1.1.1.By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Stool-Based Tests
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2.Market Share (%) 2022-2032F
11.3.1.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.3.CT Colonography
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2.Market Share (%) 2022-2032F
11.3.1.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Colonoscopy
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2.Market Share (%) 2022-2032F
11.3.1.4.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.By End User
11.3.2.1.Hospitals
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2.Market Share (%) 2022-2032F
11.3.2.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.2.Diagnostic laboratories
11.3.2.2.1.By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3.Others
11.3.2.3.1.By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
12.NORTH AMERICA COLORECTAL CANCER SCREENING MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1.By Screening Test
12.3.2.By End use
12.4. Country
12.4.1.United States
12.4.2.Canada
13.EUROPE COLORECTAL CANCER SCREENING MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1.By Screening Test
13.3.2.By End use
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4.Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14.ASIA COLORECTAL CANCER SCREENING MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1.By Screening Test
14.3.2.By End use
14.4. By Country
14.4.1.India
14.4.2.China
14.4.3.South Korea
14.4.4.Japan
14.4.5.Rest of APAC
15.MIDDLE EAST AND AFRICA COLORECTAL CANCER SCREENING MARKET SIZE & FORECAST 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1.By Screening Test
15.3.2.By End use
15.4. Country
15.4.1.Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4.South Africa
15.4.5.Rest of Middle East and Africa
16.LATIN AMERICA COLORECTAL CANCER SCREENING MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1.By Screening Test
16.3.2.By End use
16.4. Country
16.4.1.Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17.COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18.COMPANY PROFILES
18.1. Sysmex Corporation
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1 Product Portfolio
18.1.4.2 Key Clients
18.1.4.3 Market Share
18.1.4.4 Recent News & Development (Last 3 Yrs.)
18.1.4.5 Executive Team
18.2. Hemosure Inc
18.3. Epigenomics Inc
18.4. Novigenix SA
18.5. Clinical Genomics Technologies
18.6. Quidel
18.7. Siemens
18.8. GE Healthcare
18.9. Abbott
18.10. Exact Sciences
18.11. Other Prominent Players
19.APPENDIX
20.CONSULTANT RECOMMENDATION
1.1.Regional Market Share
1.2.Business Trends
1.3. Colorectal Cancer Screening Market: COVID-19 Outbreak
1.4.Regional Trends
1.5.Segmentation Snapshot
2.RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3.MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Colorectal Cancer Screening Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4.COLORECTAL CANCER SCREENING MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5.MACROECONOMIC INDICATORS
6.RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8.RISK ANALYSIS
9.MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1.Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10.COLORECTAL CANCER SCREENING MARKET
10.1. Overview
10.2. Historical Analysis (2016-2021)
10.2.1.Market Size, Y-o-Y Growth (%) and Market Forecast
11.COLORECTAL CANCER SCREENING MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Screening Test
11.3.1.1.Flexible Sigmoidoscopy
11.3.1.1.1.By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Stool-Based Tests
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2.Market Share (%) 2022-2032F
11.3.1.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.3.CT Colonography
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2.Market Share (%) 2022-2032F
11.3.1.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Colonoscopy
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2.Market Share (%) 2022-2032F
11.3.1.4.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.By End User
11.3.2.1.Hospitals
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2.Market Share (%) 2022-2032F
11.3.2.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.2.Diagnostic laboratories
11.3.2.2.1.By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3.Others
11.3.2.3.1.By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
12.NORTH AMERICA COLORECTAL CANCER SCREENING MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1.By Screening Test
12.3.2.By End use
12.4. Country
12.4.1.United States
12.4.2.Canada
13.EUROPE COLORECTAL CANCER SCREENING MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1.By Screening Test
13.3.2.By End use
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4.Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14.ASIA COLORECTAL CANCER SCREENING MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1.By Screening Test
14.3.2.By End use
14.4. By Country
14.4.1.India
14.4.2.China
14.4.3.South Korea
14.4.4.Japan
14.4.5.Rest of APAC
15.MIDDLE EAST AND AFRICA COLORECTAL CANCER SCREENING MARKET SIZE & FORECAST 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1.By Screening Test
15.3.2.By End use
15.4. Country
15.4.1.Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4.South Africa
15.4.5.Rest of Middle East and Africa
16.LATIN AMERICA COLORECTAL CANCER SCREENING MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1.By Screening Test
16.3.2.By End use
16.4. Country
16.4.1.Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17.COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18.COMPANY PROFILES
18.1. Sysmex Corporation
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1 Product Portfolio
18.1.4.2 Key Clients
18.1.4.3 Market Share
18.1.4.4 Recent News & Development (Last 3 Yrs.)
18.1.4.5 Executive Team
18.2. Hemosure Inc
18.3. Epigenomics Inc
18.4. Novigenix SA
18.5. Clinical Genomics Technologies
18.6. Quidel
18.7. Siemens
18.8. GE Healthcare
18.9. Abbott
18.10. Exact Sciences
18.11. Other Prominent Players
19.APPENDIX
20.CONSULTANT RECOMMENDATION
